AAAAAA
Results: 1-25/392
Authors:
DRIES DJ
WALENGA JM
HOPPENSTEADT D
FAREED J
Citation: Dj. Dries et al., MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION AND INFLAMMATION FOLLOWINGMAJOR INJURY - EFFECT OF THERAPY WITH IFN-GAMMA, Journal of interferon & cytokine research, 18(5), 1998, pp. 327-335
Authors:
FAREED J
Citation: J. Fareed, ANTITHROMBIN AGENTS AS ANTICOAGULANTS AND ANTITHROMBOTICS - IMPLICATIONS IN DRUG DEVELOPMENT, Clinical and applied thrombosis/hemostasis, 4(4), 1998, pp. 227-237
Authors:
AHMAD S
AHSAN A
IQBAL O
HOPPENSTEADT DA
LEWIS BE
WALENGA JM
FAREED J
Citation: S. Ahmad et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN AS STUDIED BY HPLC AND FUNCTIONAL METHODS - IMPLICATIONS IN THE MONITORING AND DOSAGE-OPTIMIZATIONS IN CARDIOVASCULAR PATIENTS, Clinical and applied thrombosis/hemostasis, 4(4), 1998, pp. 243-249
Authors:
KLAUSER RJ
HOPPENSTEADT D
FAREED J
Citation: Rj. Klauser et al., TISSUE FACTOR PATHWAY INHIBITOR IS A POTENT INHIBITOR OF PLASMIN, Clinical and applied thrombosis/hemostasis, 4(2), 1998, pp. 114-117
Authors:
DARIEN BJ
FAREED J
CENTGRAF KS
HART AP
MACWILLIAMS PS
CLAYTON MK
WOLF H
KRUSEELLIOTT KT
Citation: Bj. Darien et al., LOW-MOLECULAR-WEIGHT HEPARIN PREVENTS THE PULMONARY HEMODYNAMIC AND PATHOMORPHOLOGIC EFFECTS OF ENDOTOXIN IN A PORCINE ACUTE LUNG INJURY MODEL, Shock, 9(4), 1998, pp. 274-281
Authors:
KAISER B
GLUSA E
HOPPENSTEADT DA
BREDDIN HK
AMIRAL J
FAREED J
Citation: B. Kaiser et al., A SUPERSULFATED LOW-MOLECULAR-WEIGHT HEPARIN (IK-SSH) INCREASES PLASMA-LEVELS OF FREE AND TOTAL TISSUE FACTOR PATHWAY INHIBITOR AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION IN HUMANS, Blood coagulation & fibrinolysis, 9(6), 1998, pp. 517-523
Authors:
SCHNEIDER DM
VONTEMPELHOFF GF
HOPPENSTAEDT D
FAREED J
HEILMANN L
Citation: Dm. Schneider et al., ACQUIRED APC-RESISTANCE IN PREGNANT PATIENTS, Zeitschrift fur Geburtshilfe und Perinatologie, 202(3), 1998, pp. 107-110
Authors:
FAREED J
HOPPENSTEADT D
JESKE W
AMIRAL J
WALENGA J
Citation: J. Fareed et al., NONHEPARIN GLYCOSAMINOGLYCANS INDUCED GENERATION OF ANTIPLATELET FACTOR-4 HEPARIN ANTIBODIES - IMPLICATIONS IN THE MANAGEMENT OF HIT SYNDROME, The FASEB journal, 12(5), 1998, pp. 4157-4157
Authors:
BOZOVICH G
GURFINKEL E
MAUTNER B
BLANCO P
AMIRAL J
FAREED J
Citation: G. Bozovich et al., FREE TISSUE FACTOR PATHWAY INHIBITOR IS ELEVATED IN PATIENTS WITH ACUTE NON-Q-WAVE CORONARY SYNDROMES, The FASEB journal, 12(5), 1998, pp. 4178-4178
Authors:
IQBAL O
CALATZIS A
HAAS S
FAREED J
Citation: O. Iqbal et al., COMPARATIVE NEUTRALIZATION OF LOW-MOLECULAR-WEIGHT HEPARINS (LMWH) WITH PROTAMINE AND NEUTRALASE(R), The FASEB journal, 12(5), 1998, pp. 4179-4179
Authors:
YANG L
FU K
ARANHA R
FAREED J
Citation: L. Yang et al., PHARMACOKINETIC AND PHARMACODYNAMICS OF THE ANTIPLATELET ACTIONS OF ASYNTHETIC GPIIB IIIA INHIBITOR, SR121566/, The FASEB journal, 12(5), 1998, pp. 4180-4180
Authors:
LEITZ H
HOPPENSTEADT D
GEORGE M
FAREED J
Citation: H. Leitz et al., EFFECT OF INTRAVENOUS DEFIBROTIDE TREATMENT ON SOLUBLE P-SELECTIN LEVELS, The FASEB journal, 12(5), 1998, pp. 4182-4182
Authors:
ASHAN A
IQBAL O
AHMAD S
ANGELATS RS
WALENGA JM
FAREED J
Citation: A. Ashan et al., COMPARATIVE ANALYSES OF CIRCULATING ARGATROBAN LEVELS IN HIT PATIENTSUTILIZING HPLC AND ECT METHODS, The FASEB journal, 12(5), 1998, pp. 4183-4183
Authors:
GHANI S
FAREED J
Citation: S. Ghani et J. Fareed, EFFECT OF FACTOR XA INHIBITORS ON THE INTERNATIONAL NORMALIZED RATIO (INR) - LABORATORY AND CLINICAL IMPLICATIONS, The FASEB journal, 12(5), 1998, pp. 4184-4184
Authors:
HOPPENSTEADT D
FAREED J
AMIRAL J
JESKE W
WALENGA J
LEWIS B
WELZEL D
Citation: D. Hoppensteadt et al., TISSUE FACTOR PATHWAY INHIBITOR RELEASE IS SPECIFIC FOR HEPARINS - IMPLICATIONS IN THE MANAGEMENT OF CARDIOVASCULAR SYNDROMES, The FASEB journal, 12(5), 1998, pp. 5532-5532
Authors:
GEORGE M
HOPPENSTEADT DA
LIETZ H
AHMAD S
FAREED J
Citation: M. George et al., PERFORMANCE-CHARACTERISTICS OF 2 ELISA-BASED METHODS FOR THE QUANTITATION OF SOLUBLE THROMBOMODULIN IN PLASMA, The FASEB journal, 12(4), 1998, pp. 1114-1114
Authors:
AMIN HM
LIETZ H
HOPPENSTEADT DA
WALENGA JM
GEORGE M
AHMAD S
FAREED J
Citation: Hm. Amin et al., QUANTITATION OF SOLUBLE P-SELECTIN IN HUMAN PLASMA - EFFECT OF ANTICOAGULANT MATRIX AND PRELIMINARY CLINICAL-DATA, The FASEB journal, 12(4), 1998, pp. 1115-1115
Authors:
FAREED D
FAREED J
YANG L
HOPPENSTEADT D
JESKE W
HAAS S
MESSMORE H
Citation: D. Fareed et al., HIRUDIN DOES NOT PREVENT PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIC SYNDROMES, The FASEB journal, 12(4), 1998, pp. 1117-1117
Authors:
AHMAD S
AHSAN A
IQBAL O
HOPPENSTEADT DA
LEWIS BE
WALENGA JM
FAREED J
Citation: S. Ahmad et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF A SYNTHETIC ANTITHROMBIN AGENT, ARGATROBAN, IN MAN AS STUDIED BY HPLC AND FUNCTIONAL METHODS - IMPLICATIONS IN THE MONITORING AND DOSAGE-OPTIMIZATIONS IN CARDIOVASCULARPATIENTS, The FASEB journal, 12(4), 1998, pp. 2368-2368
Authors:
FAREED D
FAREED J
YANG L
HOPPENSTEADT D
JESKE W
HAAS S
MESSMORE H
Citation: D. Fareed et al., HIRUDIN DOES NOT PREVENT PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIC SYNDROMES, Journal of the American College of Cardiology, 31(2), 1998, pp. 24-24
Authors:
HOPPENSTEADT D
FAREED J
AMIRAL J
JESKE W
WALENGA JM
LEWIS B
WELZEL D
Citation: D. Hoppensteadt et al., TISSUE FACTOR PATHWAY INHIBITOR RELEASE IS SPECIFIC FOR HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS - IMPLICATIONS IN THE MANAGEMENT OF CORONARY SYNDROMES, Journal of the American College of Cardiology, 31(2), 1998, pp. 53-53
Authors:
YANG LH
HOPPENSTEADT D
FAREED J
Citation: Lh. Yang et al., MODULATION OF VASOCONSTRICTION BY CLOPIDOGREL AND TICLOPIDINE, Thrombosis research, 92(2), 1998, pp. 83-89
Authors:
COYNE E
MESSMORE HL
WALENGA JM
FAREED J
WEHRMACHER WH
Citation: E. Coyne et al., ETHYLENEDIAMINETETRAACETIC ACID (EDTA) IN HEPARIN, Thrombosis research, 90(5), 1998, pp. 245-246
Authors:
FU KD
IZQUIERDO R
VANDEVENDER D
WARPEHA RL
FAREED J
Citation: Kd. Fu et al., TRANSPLANTATION OF LYMPH-NODE FRAGMENTS IN A RABBIT EAR LYMPHEDEMA MODEL - A NEW METHOD FOR RESTORING THE LYMPHATIC PATHWAY, Plastic and reconstructive surgery, 101(1), 1998, pp. 134-141
Authors:
KAISER B
HOPPENSTEAD DH
WALENGA JM
GLUSA E
FAREED J
Citation: B. Kaiser et al., TISSUE FACTOR PATHWAY INHIBITOR (TFPI) HAS STRONG ANTICOAGULANT AND ANTITHROMBOTIC ACTIONS IN-VITRO AND IN-VIVO, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 426-426